Drugs and Devices

FDA approves first drug for treating Duchenne muscular dystrophy

On Sept. 19, the Food and Drug Administration (FDA) approved Exondys 51 (eteplirsen) injection, the first drug approved to treat patients with Duchenne muscular dystrophy (DMD). Read more


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares